Study of the Effect of a Fermented Dairy Product on Gastrointestinal Well Being in Adult Women

Effect of the Consumption of a Fermented Dairy Product on Gastrointestinal Well-being in a Healthy Population of Women With Minor Digestive Symptoms

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01388010

Enrollment

336

Registered

2011-07-06

Start date

2009-09-30

Completion date

2010-10-31

Last updated

2016-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adult Women

Keywords

probiotics, gastrointestinal well being, digestive symptoms, healthy population

Brief summary

The purpose of this study is to evaluate the effect of a commercially available fermented dairy product containing probiotics (4 weeks, twice a day) on the improvement of gastrointestinal well being and digestive symptoms in adult women reporting minor digestive troubles among the general population.

Interventions

OTHER1-Fermented Probiotic Dairy Product (test)

OTHER2-Milk-based non-fermented dairy product(control)

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* Female free-living subject aged from 18 to 60 years. * Subject with a body mass index between 18 and 30. * Subject with minor digestive symptoms as defined by screening questionnaire of frequency of digestive symptoms. * Subject with normal stool frequency

Exclusion criteria

* Subject with a diagnosis of Irritable Bowel Syndrome (IBS) or other functional bowel disease (constipation, diarrhoea…) * Subject with known organic disease, including an inflammatory bowel disease, a benign or malign tumour of intestine or colon and significant systemic disease * Subject under prescription for medication for digestive symptoms such as anti-spasmodic, laxatives and anti-diarrheic drugs * Subject having taken antibiotics in the last 4 weeks * Pregnant subject or subject planning to become pregnant during the study; breast-feeding subject. * Subject with known lactose intolerance or immunodeficiency * Subject with known allergy to product component (milk protein for example)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026